Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eddison Godinez Leiva

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Hypertension Reviews|December 11, 2020
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the LiverEddison Godinez-Leiva, Fernando Bril
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|November 30, 2023
Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic reviewWalter Masson, Leandro Barbagelata, Eddison Godinez-Leiva, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variantsFernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
Metabolism and Target Organ Damage|August 26, 2022
Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patientsFernando Bril, Eddison Godinez Leiva, Romina Lomonaco, et al.
Current Problems in Cardiology|February 25, 2023
Relationship of Subclinical Hypothyroidism on Epicardial Adipose Tissue: A Systematic Review and Meta-AnalysisCecilia Closs, Hernando Vargas-Uricoechea, Diego Schwarzstein, et al.
Journal of the Endocrine Society|January 1, 2026
Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance AssessmentAnu Sharma, Eddison Godinez Leiva, Srilaxmi Kalavalapalli, et al.
Diabetes, Obesity & Metabolism|April 29, 2026
High Prevalence of Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology ClinicsSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Andrea Ortiz Rocha, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2026
Severity of MASH Activity by Iron-Corrected MRI Predicts Insulin Resistance and Cardiometabolic Risk in Type 2 DiabetesAndrea Ortiz Rocha, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Journal of Hepatology|January 17, 2025
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLDDiana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Diabetes Care|December 23, 2020
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic ScreeningRomina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Hypertension Reviews|December 11, 2020
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the LiverEddison Godinez-Leiva, Fernando Bril
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|November 30, 2023
Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic reviewWalter Masson, Leandro Barbagelata, Eddison Godinez-Leiva, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variantsFernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
Metabolism and Target Organ Damage|August 26, 2022
Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patientsFernando Bril, Eddison Godinez Leiva, Romina Lomonaco, et al.
Current Problems in Cardiology|February 25, 2023
Relationship of Subclinical Hypothyroidism on Epicardial Adipose Tissue: A Systematic Review and Meta-AnalysisCecilia Closs, Hernando Vargas-Uricoechea, Diego Schwarzstein, et al.
Journal of the Endocrine Society|January 1, 2026
Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance AssessmentAnu Sharma, Eddison Godinez Leiva, Srilaxmi Kalavalapalli, et al.
Diabetes, Obesity & Metabolism|April 29, 2026
High Prevalence of Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology ClinicsSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Andrea Ortiz Rocha, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2026
Severity of MASH Activity by Iron-Corrected MRI Predicts Insulin Resistance and Cardiometabolic Risk in Type 2 DiabetesAndrea Ortiz Rocha, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Journal of Hepatology|January 17, 2025
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLDDiana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Diabetes Care|December 23, 2020
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic ScreeningRomina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.
Pageof 2